Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024
Months
January February March April May June July August September October November December
Previous Archive
18 September 2018
Soccer ladies relish challenge in Potch
Trinity Melakeco (right) in action for the Kovsie women’s soccer team against the Tshwane University of Technology (TUT) last year. They will face TUT, the defending champions, on Friday 21 September in Varsity Women’s Football.
The Kovsie women’s soccer team has a tough challenge ahead of them in their quest to reach the semi-finals of Varsity Women’s Football for the first time.

The tournament starts on Thursday 20 September 2018 in Potchefstroom. The Kovsies’ best performance in the competition was in 2016, when they were fifth.

They are in the same group as the University of Johannesburg (UJ), the University of KwaZulu-Natal (UKZN), and Tshwane University of Technology (TUT). TUT has dominated Varsity Women's Football, winning four of the five tournaments. TUT and UJ contested the final last year, as well as the University Sport South Africa (USSA) tournament in July.

Kovsie coach, Godfrey Tenoff, says the challenge of playing the top-seeds is one they relish and welcome.

According to him, the ladies will have gained confidence from USSA where they ended sixth, improving by two places from 2017.

“We were satisfied with our performance at USSA. There are so much the players are capable of, but they don’t get the platform to test their talents as often as the men. We only play UJ and TUT once or twice a year, and there are very few teams in our province with that much talent. So, we have to get out more and find opportunities to play against top-teams to put our preparations and methods to the test.”

“We’ve had a good defence all season, led by our captain, Uma Jakalase. This will have to get us through the tournament.”

* The fixtures: 20 Sept vs UKZN; 21 Sept vs. TUT and UJ. The play-off matches are scheduled for Saturday.

News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept